Clinical Insights into Vascular Dementia: From Pathophysiology to Risk Assessment

Dementia encompasses a spectrum of syndromes characterized by progressive cognitive decline that impairs memory, behavior, and activities of daily living. Among the various subtypes, Alzheimer’s disease (AD) is the most prevalent, accounting for up to 75% of cases, followed by vascular dementia (VaD), which represents the second most common cause, particularly among older adults. VaD results from diminished cerebral perfusion secondary to vascular pathology such as stroke, which leads to neuronal death and subsequent cognitive impairment. The prevalence of VaD varies geographically, with estimates ranging from 10-15% in developed nations and reaching up to 30% in developing countries. Pathophysiologically, VaD is associated with reduced cerebral blood flow, small vessel disease, and oxidative stress. Major contributory factors include advancing age, cardiovascular risk factors, and lifestyle elements. Vascular damage induces neuroinflammation, oxidative damage, and neuronal necrosis, thereby exacerbating cognitive deficits. Experimental models for studying VaD include techniques such as cerebral vessel occlusion, high-fat diet models, and chemical induction, each designed to replicate different aspects of the disease’s underlying mechanisms. Clinically, VaD presents with cognitive and behavioral deficits similar to those observed in AD but is often distinguished by a stepwise progression of symptoms and evidence of vascular pathology in the brain. Risk factors for VaD strongly overlap with those for cerebrovascular disease, including hypertension, diabetes mellitus, and hyperlipidemia. A comprehensive understanding of these mechanisms and risk factors is essential for the development of effective therapeutic and preventative interventions for vascular dementia.